An interesting piece in the Chicago Tribune unveiled Merck's latest plans for turning the embattled drugmaker's fiscal fortunes around with the help of three new vaccines in the FDA regulatory pipeline:
Gardasil, a drug intended to protect women from four kinds of human papillomavirus,
that accounts for the lion's share of cervical cancer cases.
Zostavax, a vaccine for shingles.
Rotateq, an oral remedy for common gastrointestinal illnesses in children.
The company is certainly looking for a home run, considering its well-publicized legal wrangling with patients over the health-harming Vioxx, and Zocor running out of patent protection.
However, what you and many other consumers may not recall -- and what Merck is probably betting on -- is news of a scandal I posted earlier this year involving the mislabeling of hepatitis B vaccines for babies that weren't thimerosal-free.
Chicago Tribune December 14, 2005 Registration Required
Integrated Medicine Forum
Complementary and alternative medicine (CAM) Blog - Stories and opinion about health, illness and medicine
Sunday, December 25, 2005
Merck Turns To Vaccines To Save The Day
Subscribe to:
Post Comments (Atom)
ClickComments
Dr. Group's Secret to Health Kit$39.94 Dr. Group's Secret to Health Kit offers simple at-home solutions for cleansing internally and externally thereby reducing toxins, restoring the body's natural healing process, and helping you achieve true health and happiness. |
No comments:
Post a Comment